Aesthetic and clinic inventory solutions
Benefits for Gut Health: Targets pathogens without harming beneficial bacteria Helps eliminate mold, yeast, and biofilm Improves immune surveillance in the gut lining Supports wound healing and epithelial integrity Clinical Context: LL-37 is ideal for patients with dysbiosis, recurrent infections, SIFO (small intestinal fungal overgrowth), or mold-related illness
Sensitivity analyses showed that the probability of using GLP-1RAs versus insulin being cost-effective for preventing one case of all-cause mortality or hospitalized hypoglycemia ranged from 60 to 100%
refer to COA for component ratio) Strength: 70 mg total peptide content per vial Purity: 99% (HPLC verified, each component) Container: sealed glass vial (lyophilized powder) Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for all three component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
J.CarrerasA.Rodrguez-SerranoM.EstebanF
Products that support adequacy without medicalized claims can help stabilize intake